Navigation Links
HOYA ConBio Announces Educational Agreement With LVI Global
Date:2/20/2008

HOYA ConBio Lasers Featured At Premier Las Vegas Training Facility

FREMONT, Calif., Feb. 20 /PRNewswire/ -- HOYA ConBio(TM), a global leader in dental and aesthetic lasers, today announced an agreement with The Las Vegas Institute for Advanced Dental Studies (LVI), an internationally recognized leader in post-graduate dental education, in which VersaWave(TM) and DioDent(TM) Micro 980 lasers will be utilized at LVI's state-of-the-art teaching facility through 2009. The educational alliance is the latest development in HOYA ConBio's corporate outreach to partner with pioneers in dental continuing education.

"In the past, we've selected LVI as the host site for our HOYA ConBio College for laser dentistry training," said Timothy S. Gehlmann, President & CEO, HOYA ConBio. "This agreement takes our relationship to a new level and we are excited to move forward with comprehensive laser course offerings, providing a complete portfolio of products to achieve superior clinical results."

HOYA ConBio's VersaWave and DioDent Micro 980 dental lasers will be placed at LVI's 62,000 square-foot facility, which features two 10-operatory teaching clinics, a 60 bench hands-on workshop and six lecture halls. According to William G. Dickerson, DDS, LVI Global's founder and CEO, practicing dentists worldwide visit LVI to advance their education, knowledge and expertise in aesthetic, neuromuscular, occlusal, restorative and reconstruction dentistry.

"We share HOYA ConBio's belief that training is paramount to successful dentistry and we are pleased to feature their dental lasers at our first-class facility," commented Dennis Bonilla, LVI Global President. "Since 1995, LVI has set standards for clinical education in dentistry and our graduates are among the finest, most progressive dentists in the world. HOYA ConBio's dental lasers will be an integral part of our curriculum, available to the more than 6,000 LVI clinical alumni who attend our courses to learn and practice advanced laser procedures."

The VersaWave Erbium hard-tissue laser is used for state-of-the-art instruction in soft tissue smile design, smile lift procedures, frenectomies and hard tissue application in closed flap, open flap and pre-prosthetic surgical procedures. The DioDent Micro 980 is a next-generation diode laser for use in a wide variety of procedures, including excisional and incisional biopsies, fibroma removal, gingivectomy, gingivoplasty, oral papillectomies and sulcular debridement.

About HOYA ConBio: HOYA ConBio designs, manufactures and markets sophisticated laser systems used in dental and aesthetic medical practices worldwide, widely recognized by practitioners as "The World's Most Reliable Lasers(TM)." The company's innovative technologies are highly versatile, clinically effective, and offer rapid return on investment. Headquartered in Fremont, CA, HOYA ConBio maintains a worldwide product and service distribution network. For more information, call 800-532-1064 or visit http://www.conbio.com.

About LVI Global: The Las Vegas Institute for Advanced Dental Studies is the world's premier post-graduate dental teaching center, specializing in training aesthetic and neuromuscular dentists. Founded in 1995, LVI was established to educate, guide and support dentists in the delivery of the most advanced patient-based care possible. For more information, contact 1.888.584.3237 or visit http://www.lviglobal.com.


'/>"/>
SOURCE HOYA ConBio
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CleanRest(R) Announces a Groundbreaking Invention, The Worlds Cleanest Pillow(TM)
2. Varian Medical Systems Announces Symposia on RapidArc Technology for Faster, More Precise Radiotherapy Treatments
3. Thermage Announces Fourth Quarter and Full Year 2007 Financial Results
4. XTENT Announces 2007 Financial Results
5. VA Secretary Announces New Walla Walla Facility
6. TrailBlazer Announces Final Medicare Administrative Contractor Schedule for Claims Processing in Four States
7. Pennsylvania Department of Public Welfare Announces Grant Opportunity for Regional Autism Centers
8. Paine & Partners, LLC Announces Sale of Byram Healthcare to OPG Groep N.V.
9. MedCath Announces Venture With Two New Jersey Hospitals
10. Nu Skin Enterprises Announces Increase in Quarterly Dividend
11. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar; Previously Announced Fourth Quarter and Full Year 2007 Financial Results Teleconference Rescheduled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of the most ... touted to be the next revolution in our fight against this complex disease. One ... of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While a few ...
(Date:3/29/2017)... (PRWEB) , ... March 29, ... ... suburbs and South Hills of Pittsburgh now have easier access to the ... only by Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital and ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of ... Julie Taffet Moelis, W’81, have made a $10 million gift to establish the ... that will provide a pathway to a Wharton MBA for highly-qualified Penn undergraduates whose ...
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over ... recently, the only option for on-premises installation of its Help System for SharePoint was ... install the system into the entire tenant. , The company recently released a ...
(Date:3/28/2017)... ... ... Tuesday, March 28, 2017, is the annual American Diabetes Association Alert Day, ... find out if they are at risk for developing Type 2 diabetes. In recognition ... by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower Crown Lights ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017   Royal Philips (NYSE: ... technology, and PathAI, a company that develops artificial ... aim to develop solutions that improve the precision ... other diseases. The partnership aims to build deep ... of artificial intelligence to be applied to massive ...
(Date:3/29/2017)... 2017 Neurim Pharmaceuticals ("Neurim") and ... exclusive marketing rights for Neurim,s new Rx PedPRM in ... ... sleep disorders in children with Autism Spectrum Disorders (ASD) and neurogenetic ... for children. The collaboration with Exeltis will help increase ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "Global ... to their offering. ... The global patient safety and risk management software market is ... Patient safety has become a priority for almost all ... in the last decade and is currently on the verge of ...
Breaking Medicine Technology: